search
Back to results

Exercise Training in Pregnancy for Obese Mothers

Primary Purpose

Pregnancy, Obesity

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Exercise
Sponsored by
Norwegian University of Science and Technology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pregnancy focused on measuring Exercise training, Pregnancy, Obesity

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Pre-pregnancy body mass index of 28 or more
  • 18 years or more
  • singleton live fetus at the routine ultrasound scan

Exclusion Criteria:

  • high risk for preterm labor or diseases that could interfere with participation

Sites / Locations

  • Norwegian University of Science and Technology

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Exercise training

Control

Arm Description

Supervised exercise training at the hospital during pregnancy: the women will attend at least 2 weekly sessions consisting of aerobic exercise (walking on treadmills), strength training (for upper body, back, abdomen and legs) as well as pelvic floor muscle exercises. Each session is 60 minutes and lead by a physiotherapist or experienced exercise physiologist. The women will also go through motivational interviewing sessions throughout the intervention period and are encouraged to do home exercise training in addition to the exercise at the hospital

Usual care as provided by the health services in Norway. The investigators will not advice the women to be inactive

Outcomes

Primary Outcome Measures

Weight gain during pregnancy
Measured in kg

Secondary Outcome Measures

Fasting glucose
Blood samples to determine the fasting glucose after an overnight fast (>10 hours)
Glucose tolerance
2 hour 75 mg per-oral glucose tolerance test. Gestational diabetes is diagnosed as fasting glucose = or > 6.9 mmol/L or 2h concentration = or > 7.8 mmol/L.
Insulin resistance
Homeostasis model assessment (HOMA-IR)
Body composition
Skinfold measurements, done by an experienced investigator using Harpenden kaliper. At the 3 months postpartum testing, also dual energy x-ray absorptiometry (DEXA scan) will be used.
Blood markers for cardiovascular disease
Inflammation markers, cytokines (leptin, resistin, adiponectin, tnf-alfa). Blood will be collected and stored for later analyses.
Lumbopelvic pain
Clinical assessment (active straight leg raising, pelvic provocation test), and validated questionnaire.
Urin- and fecal incontinence
Pelvic floor muscle function will be assessed by clinical assessment and by 2D and 3D ultrasound. The prevalence and severity of urin- and fecal incontinence will also be assessed by a validated questionnaire
Quality of life
Validated questionnaire
Sleep
Epworth sleepiness scale
Physical activity
Level of physical activity will be assessed by activity registration (armbands) and by validated questionnaires
Diet
Validated questionnaire: Norkost
Offspring birth weight, length and head circumference
As recorded by the hospital
Delivery complications
Vaginal or caesarean delivery, and recorded complications during the delivery
Markers of inflammation and metabolism in cord blood
Cord blood will be sampled and stored for later analysis of relevant markers of inflammation and metabolism (including resistin, leptin, adiponectin)

Full Information

First Posted
September 6, 2010
Last Updated
January 24, 2020
Sponsor
Norwegian University of Science and Technology
Collaborators
Harvard Medical School (HMS and HSDM), Norwegian School of Sport Sciences, Karolinska Institutet, St. Olavs Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01243554
Brief Title
Exercise Training in Pregnancy for Obese Mothers
Official Title
Exercise Training in Pregnancy. Good for the Mother - Good for the Child?
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
September 2010 (undefined)
Primary Completion Date
June 2015 (Actual)
Study Completion Date
June 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology
Collaborators
Harvard Medical School (HMS and HSDM), Norwegian School of Sport Sciences, Karolinska Institutet, St. Olavs Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Observational studies demonstrate that overweight in pregnancy is a risk factor for adverse pregnancy outcomes as fetal macrosomia, prolonged labor, low Apgar score, shoulder dystocia, nerve plexus injuries, increased proportion of instrumental deliveries and perineal ruptures. There is a 2.6 fold risk for gestational diabetes mellitus (fourfold in morbidly obese women) and a recent study has shown that fetuses of obese mothers develop insulin resistance in uterus. Main aims of this study are to assess if regular exercise in pregnancy among obese women can prevent or influence weight gain; impaired cardiac function in mother and fetus/newborn; impaired vascular function in mother; insulin resistance/sensitivity; body composition in mother and offspring; lumbopelvic pain; urinary and/or fecal incontinence; prolonged labor
Detailed Description
Women with a self-reported pre-pregnancy BMI of 28 or more will be eligible for our study. Woman are eligible if they are 18 years or older, with a singleton live fetus at an early (week 12-14) ultrasound scan. Exclusion criteria are pregnancy complications with high risk for preterm labour or diseases that could interfere with participation. Primary outcome measure is weight increase based on weight measured at 14 weeks and immediately before labour. Assessments are done at baseline at 14 (12-18) weeks of pregnancy, and again in week 38, as well as 3 months postpartum. Some measurements are also done at other points in time. The maternal secondary outcome measurements include fasting glucose, glucose tolerance assessed by 2-h, 75 mg per-oral glucose tolerance test, insulin resistance assessed by HOMA-IR, weight, height, body composition estimated by skinfold measurements in pregnancy and by dual energy x-ray absorptiometry postpartum, blood markers, lumbopelvic pain, urin- and fecal incontinence, quality of life, psychological wellbeing, depression, and diet.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pregnancy, Obesity
Keywords
Exercise training, Pregnancy, Obesity

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
91 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercise training
Arm Type
Experimental
Arm Description
Supervised exercise training at the hospital during pregnancy: the women will attend at least 2 weekly sessions consisting of aerobic exercise (walking on treadmills), strength training (for upper body, back, abdomen and legs) as well as pelvic floor muscle exercises. Each session is 60 minutes and lead by a physiotherapist or experienced exercise physiologist. The women will also go through motivational interviewing sessions throughout the intervention period and are encouraged to do home exercise training in addition to the exercise at the hospital
Arm Title
Control
Arm Type
No Intervention
Arm Description
Usual care as provided by the health services in Norway. The investigators will not advice the women to be inactive
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Other Intervention Name(s)
Training
Intervention Description
Exercise training at the hospital
Primary Outcome Measure Information:
Title
Weight gain during pregnancy
Description
Measured in kg
Time Frame
From 14 weeks pregnancy to delivery
Secondary Outcome Measure Information:
Title
Fasting glucose
Description
Blood samples to determine the fasting glucose after an overnight fast (>10 hours)
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Glucose tolerance
Description
2 hour 75 mg per-oral glucose tolerance test. Gestational diabetes is diagnosed as fasting glucose = or > 6.9 mmol/L or 2h concentration = or > 7.8 mmol/L.
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Insulin resistance
Description
Homeostasis model assessment (HOMA-IR)
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Body composition
Description
Skinfold measurements, done by an experienced investigator using Harpenden kaliper. At the 3 months postpartum testing, also dual energy x-ray absorptiometry (DEXA scan) will be used.
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Blood markers for cardiovascular disease
Description
Inflammation markers, cytokines (leptin, resistin, adiponectin, tnf-alfa). Blood will be collected and stored for later analyses.
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Lumbopelvic pain
Description
Clinical assessment (active straight leg raising, pelvic provocation test), and validated questionnaire.
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Urin- and fecal incontinence
Description
Pelvic floor muscle function will be assessed by clinical assessment and by 2D and 3D ultrasound. The prevalence and severity of urin- and fecal incontinence will also be assessed by a validated questionnaire
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Quality of life
Description
Validated questionnaire
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Sleep
Description
Epworth sleepiness scale
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Physical activity
Description
Level of physical activity will be assessed by activity registration (armbands) and by validated questionnaires
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Diet
Description
Validated questionnaire: Norkost
Time Frame
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Title
Offspring birth weight, length and head circumference
Description
As recorded by the hospital
Time Frame
At delivery
Title
Delivery complications
Description
Vaginal or caesarean delivery, and recorded complications during the delivery
Time Frame
At delivery
Title
Markers of inflammation and metabolism in cord blood
Description
Cord blood will be sampled and stored for later analysis of relevant markers of inflammation and metabolism (including resistin, leptin, adiponectin)
Time Frame
At delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pre-pregnancy body mass index of 28 or more 18 years or more singleton live fetus at the routine ultrasound scan Exclusion Criteria: high risk for preterm labor or diseases that could interfere with participation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Trine T Moholdt, PhD
Organizational Affiliation
Norwegian University of Science and Technology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Norwegian University of Science and Technology
City
Trondheim
ZIP/Postal Code
7489
Country
Norway

12. IPD Sharing Statement

Citations:
PubMed Identifier
27459375
Citation
Garnaes KK, Morkved S, Salvesen O, Moholdt T. Exercise Training and Weight Gain in Obese Pregnant Women: A Randomized Controlled Trial (ETIP Trial). PLoS Med. 2016 Jul 26;13(7):e1002079. doi: 10.1371/journal.pmed.1002079. eCollection 2016 Jul.
Results Reference
result
PubMed Identifier
28323893
Citation
Garnaes KK, Nyrnes SA, Salvesen KA, Salvesen O, Morkved S, Moholdt T. Effect of supervised exercise training during pregnancy on neonatal and maternal outcomes among overweight and obese women. Secondary analyses of the ETIP trial: A randomised controlled trial. PLoS One. 2017 Mar 21;12(3):e0173937. doi: 10.1371/journal.pone.0173937. eCollection 2017.
Results Reference
result
PubMed Identifier
29310617
Citation
Garnaes KK, Morkved S, Salvesen KA, Salvesen O, Moholdt T. Exercise training during pregnancy reduces circulating insulin levels in overweight/obese women postpartum: secondary analysis of a randomised controlled trial (the ETIP trial). BMC Pregnancy Childbirth. 2018 Jan 8;18(1):18. doi: 10.1186/s12884-017-1653-5.
Results Reference
result
PubMed Identifier
29856768
Citation
Nyrnes SA, Garnaes KK, Salvesen O, Timilsina AS, Moholdt T, Ingul CB. Cardiac function in newborns of obese women and the effect of exercise during pregnancy. A randomized controlled trial. PLoS One. 2018 Jun 1;13(6):e0197334. doi: 10.1371/journal.pone.0197334. eCollection 2018.
Results Reference
result
PubMed Identifier
31753866
Citation
Garnaes KK, Helvik AS, Stafne SN, Morkved S, Salvesen K, Salvesen O, Moholdt T. Effects of supervised exercise training during pregnancy on psychological well-being among overweight and obese women: secondary analyses of the ETIP-trial, a randomised controlled trial. BMJ Open. 2019 Nov 21;9(11):e028252. doi: 10.1136/bmjopen-2018-028252.
Results Reference
result
PubMed Identifier
32378735
Citation
Woodley SJ, Lawrenson P, Boyle R, Cody JD, Morkved S, Kernohan A, Hay-Smith EJC. Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev. 2020 May 6;5(5):CD007471. doi: 10.1002/14651858.CD007471.pub4.
Results Reference
derived
PubMed Identifier
25761057
Citation
Ingul CB, Loras L, Tegnander E, Eik-Nes SH, Brantberg A. Maternal obesity affects fetal myocardial function as early as in the first trimester. Ultrasound Obstet Gynecol. 2016 Apr;47(4):433-42. doi: 10.1002/uog.14841. Epub 2016 Mar 14.
Results Reference
derived
PubMed Identifier
21682869
Citation
Moholdt TT, Salvesen K, Ingul CB, Vik T, Oken E, Morkved S. Exercise Training in Pregnancy for obese women (ETIP): study protocol for a randomised controlled trial. Trials. 2011 Jun 17;12:154. doi: 10.1186/1745-6215-12-154.
Results Reference
derived

Learn more about this trial

Exercise Training in Pregnancy for Obese Mothers

We'll reach out to this number within 24 hrs